Integrating Peptide Therapy into Existing Treatment Protocols Peptide therapies can be easily incorporated into current treatment regimens for chronic conditions
Glutaminolysis feeds Mtorc1
The full list of exclusion criteria is available in the Supplementary material
Future frameworks will likely need to incorporate guidance for engineered strains, synbiotics, microbial consortia, and microbiome-based therapeutics, extending the FAO/WHO principles to more complex products while maintaining their core focus on strain specificity, safety, and evidence-based health benefits (531)
doi: 10.3389/fcimb.2021.657775 Received 24 January 2021 Accepted 11 May 2021 Published 03 June 2021 Volume 11 - 2021 Edited by Diego Luis Costa, University of So Paulo, Brazil Reviewed by Maria Regina DImprio Lima, University of So Paulo, Brazil
- Kch thch ti to t bo da mi, thay th cc t bo da cht